Neutral metoclopramide induces tumor cytotoxicity and sensitizes ionizing radiation of a human lung adenocarcinoma and virus induced sarcoma in mice

Acta Oncologica

Volumn 36, Issue 3, 1997, Pages 323-330

  Olsson, Anders R ^a   Hua, Jianyi ^a   Sheng, Yezhou ^a   Pero, Ronald W ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG CARCINOMA; MOUSE; PRIORITY JOURNAL; RADIOSENSITIZATION; SARCOMA; TUMOR XENOGRAFT;

EID: 0030970355     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001271     Document Type: Article

References (33)

1. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide. An updated reveiw of its pharmacological properities and and clinical use. Drugs 1983, 25: 451-94.
2. Hua J, Olsson A, Sheng Y, Pero RW. Acidic and neutralized metoclopramide formulations sensitize ionizing radiation induced cytotoxicity in a human lung adenocarcinoma xenografted to scid mice. Anticancer Drugs 1995; 6: 451-5.
3. Kjellén E, Wennerberg J, Pero RW. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinomas of the head and neck. Br J Cancer 1989; 59: 247-50.
4. Lybak S, Kjellén E, Wennerberg J, Pero RW. Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1990; 19: 1419-24.
5. Lybak S, Kjellén E, Nilsson P, Tomaszewicz A, Wennerberg J, Pero RW. Normal tissue reactions and optimization of dose schedule for metoclopramide in combination with ionizing radiation. Acta Oncol 1992; 31: 469-474.
6. Salford LG, Brun AT, Aas A, Pero RW. Metoclopramide as a sensitizer of 1,3- Bis(2-chloroethyl)-1-nitrosourea (BCNU) treatment of brain tumors in the rat. Anticancer Drugs 1992, 3: 267-72.
7. Kjellén E, Pero RW, Brun E, et al. A phaseI II evaluation of metoclopramide as a radiosensitizer in patients with inoperable squamos cell carcinoma of the lung. Eur J Cancer 1995; 31A: 2196-202.
8. Pero RW, Olsson A, Sheng Y, et al. Progress in identifying clinical relevance of inhibition, stimulation and measurement of poly ADP-ribosylation. Biochemie 1995; 77: 385-93.
9. Lybak S, Pero RW. The benzamide derivative metoclopramide causes DNA damage and inhibition of DNA repair in human peripheral mono nuclear leukocytes at clinically relevant doses. Carcinogenesis 1991; 12: 1613-7.
10. Olsson A, Sheng Y, Kjellén E, Pero RW. In vivo measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide. Carcinogenesis 1995; 16: 1029-35.
11. Pero RW, Simanaitis M, Olsson A, et al. Pharmacokinetics, toxicity, side effects, receptor affinities and in vitro radiosensitizing effects of the novel metoclopramide formulations, sensamide and neu-sensamide. Pharmacol Toxicol 1997 (In Press).
12. Radford IR. Mouse lymphoma cells that undergo interphase death show markedly increased sensitivity to radiation-induced DNA double-strand breakage as compared with cells that undergo mitotic death. Int J Radiat Biol 1991; 59: 1353-69.
13. D'Amico AV, McKenna WG. Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother Oncol 1994; 33: 3-10.
14. Horwich A. Cancer research campaign review of radiation research. Br J Cancer 1993; 67: 198-201.
15. Meyn RE, Stephens LC, Voehringer DW. et al. Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells. Radiat Res 1993; 136: 327-34.
16. Mirkovic N, Meyn RE, Hunter NR, Milas L. Radiation-induced apoptosis in a murine lymphoma in vivo. Radiother Oncol 1994; 33: 11-6.
17. Tauchi H, Sawada S. Analysis of mitotic cell death in mouse leukaemia L5178 cells: apoptosis is the ultimate form of cell death following mitotic failure. Int J Radiat Biol 1994; 65: 449-55.
18. Kaufman SH, Desnoyers S, Ottaviano Y, et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy induced apoptosis. Cancer Res 1993; 53: 3976-85.
19. Reed JC. Regulation of apoptosis by bcl-2 family proteins and ils role in cancer and chemoresistance. Curr Opin Oncol 1995; 7: 541-6.
20. Kerr FR, Winterford CM. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1993; 73: 2013-26.
21. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin in Cell Biol 1995; 7: 337-43.
22. ™) induces tumor cytotoxicity and sensitizes ionizing radiation in a human lung adenocarcinoma and in an adenotype 12 virus induced mouse sarcoma. Radiother Oncol 1996, 40 (Suppl): S48.
23. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-30.
24. Schreiber GJ, Hellström KE, Hellström I. An unmodified anti carcinoma antibody BR96, localizes to and inhibits the outgrowth of human tumors in nude mice. Cancer Res 1992; 52: 3252-66.
25. Attia MAM, Weiss DW. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumour resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 1966; 26: 1787-90.
26. Berman R, Steel GG. Induced and inherent resistance to alkylating agents in human small-cell broncial carcinoma xenografts. Br J Cancer 1984; 49: 431-6.
27. Meyn Rt, Stephens LC, Ang KK, et al. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol 1993; 64: 583-91.
28. Fisher DA. Apoptosis in cancer therapy: Crossing the threshold. Cell 1996: 78: 539-47.
29. Ling CC, Guo M, Chen CH, Deloherey T. Radiation-induced apoptosis: Effects of age and dose fraetionation. Cancer Res 1995; 55: 5207-12.
30. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer 1996; 74: 1743-8.
31. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1-9.
32. Werning JW, Stepnick DW, Jafri A, Megerian CA, Antunez AR, Syed IA. Metoclopramide enhances the effect of photodynamic therapy on xenografted humansquamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1995; 121: 783-9.
33. Zaidi SIA, Oleinick NL, Zaim MT, Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-tumors in C3H mice: electron microscopic, histopatologic and biochemical evidence. Photochem Photobiol 1993; 58: 771-6.